Stericycle Inc (NASDAQ:SRCL) – Stock analysts at Northcoast Research lowered their Q2 2019 earnings per share estimates for shares of Stericycle in a research note issued to investors on Monday, May 6th, Zacks Investment Research reports. Northcoast Research analyst D. Keiser now forecasts that the business services provider will post earnings of $0.85 per share for the quarter, down from their prior forecast of $0.88. Northcoast Research also issued estimates for Stericycle’s FY2019 earnings at $3.31 EPS, Q1 2020 earnings at $0.79 EPS, Q2 2020 earnings at $0.93 EPS and FY2020 earnings at $3.84 EPS.
Stericycle (NASDAQ:SRCL) last released its earnings results on Thursday, February 28th. The business services provider reported $1.03 earnings per share for the quarter, beating analysts’ consensus estimates of $0.96 by $0.07. The firm had revenue of $852.70 million during the quarter, compared to the consensus estimate of $848.75 million. Stericycle had a positive return on equity of 12.56% and a negative net margin of 8.92%.
Several other analysts also recently weighed in on the company. BidaskClub downgraded Stericycle from a “buy” rating to a “hold” rating in a research report on Wednesday, May 8th. Zacks Investment Research downgraded Stericycle from a “hold” rating to a “strong sell” rating in a research report on Tuesday, May 7th. Robert W. Baird downgraded Stericycle from a “neutral” rating to an “underperform” rating and set a $44.00 price objective for the company. in a research report on Wednesday, April 17th. ValuEngine downgraded Stericycle from a “hold” rating to a “sell” rating in a research report on Monday, April 1st. Finally, BMO Capital Markets upped their price objective on Stericycle to $50.00 and gave the stock a “market perform” rating in a research report on Friday, March 22nd. Four equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and three have given a buy rating to the stock. Stericycle presently has a consensus rating of “Hold” and an average price target of $59.00.
Shares of NASDAQ:SRCL traded up $1.01 during trading on Tuesday, reaching $46.38. 839,668 shares of the company traded hands, compared to its average volume of 1,134,978. The company has a debt-to-equity ratio of 1.17, a quick ratio of 1.02 and a current ratio of 1.02. Stericycle has a 52 week low of $34.36 and a 52 week high of $71.43. The company has a market cap of $4.22 billion, a price-to-earnings ratio of 10.42, a PEG ratio of 1.78 and a beta of 1.11.
In other Stericycle news, Director Mark C. Miller sold 260,314 shares of the stock in a transaction dated Tuesday, April 9th. The stock was sold at an average price of $57.18, for a total value of $14,884,754.52. Following the completion of the transaction, the director now directly owns 325,848 shares in the company, valued at $18,631,988.64. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 2.30% of the stock is currently owned by company insiders.
Institutional investors have recently bought and sold shares of the business. JOYN Advisors Inc. increased its stake in shares of Stericycle by 1,253.7% in the fourth quarter. JOYN Advisors Inc. now owns 731 shares of the business services provider’s stock valued at $27,000 after buying an additional 677 shares during the period. Bronfman E.L. Rothschild L.P. grew its stake in Stericycle by 159.5% during the fourth quarter. Bronfman E.L. Rothschild L.P. now owns 807 shares of the business services provider’s stock worth $30,000 after purchasing an additional 496 shares during the period. Pearl River Capital LLC acquired a new stake in Stericycle during the fourth quarter worth approximately $41,000. Blue Sky Asset Management LLC acquired a new stake in Stericycle during the first quarter worth approximately $60,000. Finally, Quadrant Capital Group LLC grew its stake in Stericycle by 1,186.8% during the first quarter. Quadrant Capital Group LLC now owns 1,171 shares of the business services provider’s stock worth $61,000 after purchasing an additional 1,080 shares during the period. Hedge funds and other institutional investors own 96.52% of the company’s stock.
Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It operates through three segments: Domestic and Canada Regulated Waste and Compliance; International Regulated Waste and Compliance; and Domestic Communication and Related Services.